Heparin Ratiopharm 60,000 Ointment 150 g
Supports healthy circulation and reduces swelling
Category: Topical Care / Circulatory Support
Purpose: Helps prevent and treat superficial thrombosis, bruises, and minor vein congestion
What It Is
Heparin Ratiopharm 60,000 Ointment contains heparin sodium, a well-known active ingredient that supports normal blood flow in superficial veins. The ointment is used to prevent blood clots in superficial veins, reduce inflammation, and accelerate the resorption of bruises and hematomas. Its smooth formulation allows easy topical application to affected areas, promoting circulation and comfort.
✅ Key Benefits
-
Supports healthy circulation in superficial veins
-
Helps reduce swelling and inflammation
-
Accelerates healing of bruises and hematomas
-
Easy-to-apply ointment for local treatment
-
Suitable for prevention and treatment of minor vein congestion
Use & Dosage
Adults: Apply a thin layer to the affected area 2–3 times daily and gently massage until absorbed.
Use consistently for several days or as advised by a healthcare professional.
Wash hands before and after application.
⚠️ Safety & Precautions
-
Not suitable for children under 12 years without medical advice.
-
Avoid application on open wounds or mucous membranes.
-
Consult a doctor if swelling, pain, or discoloration worsens.
-
Keep out of reach of children.
-
Use under medical supervision during pregnancy or breastfeeding.
Product Details
Form: Ointment
Active Ingredients: Heparin sodium 60,000 IU per 100 g
Target Group: Adults and adolescents ≥12 years
Pack Size: 150 g
Buy Heparin Ratiopharm 60,000 Ointment 150 g
Support circulation, reduce swelling, and aid bruise healing effectively with Heparin Ratiopharm — available at Pharmeu.
SEO Keywords:
Heparin Ratiopharm ointment, topical heparin 60,000, bruise healing ointment, vein congestion treatment, anti-inflammatory heparin cream, Heparin Ratiopharm 150 g, circulation support ointment, hematoma reduction cream, superficial thrombosis ointment, heparin skin application
.
